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resulted in a 20-fold increase of RHAMM on the cell Response to Hofmann et al.
surface (see Table 1 of Hall et al., 1995). Curiously, the
same RHAMM1v4 isoform expressed in the same cells
RHAMM belongs to a group of hyaladherins that regu-was later reported to be located exclusively in the cyto-
late cell motility and cell cycle and that are expressedplasm (Zhang et al., 1998).
in the cytoplasm, nucleus, and cell surface, in spite ofQuestions about the physiological significance of the
a lack of signal peptide or transmembrane domain. Com-RHAMM transformation data are raised by the fact that
plexity of RHAMM distribution and transient expressionthe link between surface hyaluronan binding and trans-
of its small isoforms lies at the heart of the currentformation has become doubtful and that the transforma-
controversy. We first reported the full-length long formtion studies used a truncated and incompletely pro-
of the human RHAMM cDNA (Wang et al., 1996). Thiscessed RHAMM cDNA clone. The same is true of other
cDNA was later recloned by Assmann et al. (1998). Hof-work using these truncated murine RHAMM constructs
mann et al. (1998) obtained the murine homolog. A(e.g., Zhang et al., 1998). Nonetheless the role of this
smaller RHAMM isoform (v4; Hall et al., 1995) was vari-protein in transformation still warrants further investiga-
ably detected in 3T3 cells with 59 RACE, primer exten-tion and could yet represent a novel pathway of onco-
sion, and RT-PCR and corresponded to a minor 70±73genic activity.
kDa protein (references in Zhang et al., 1998). This iso-
form is constitutively detected by RT-PCR in ras-trans-
formed cells, the 59 UTR is present in the RHAMM geneMartin Hofmann,*³ Volker Assmann,² Christina Fieber,*
(unpublished data), and this isoform is transformingJonathan P. Sleeman,* JuÈ rgen Moll,* Helmut Ponta,*
when overexpressed in 10T1/2 fibroblasts. Regrettably,Ian R. Hart,² and Peter Herrlich*
in our Cell manuscript, we did not report a compari-*Forschungszentrum Karlsruhe and
son between the transfected v4 and native v4 proteins.University of Karlsruhe
In RHAMMv4 transformed cells, surface RHAMM wasInstitutes of Genetics
elevated and we mistakenly predicted this surfaceD-76021 Karlsruhe, Germany
population to be v4 (Hall et al., 1995). Subsequent epi-²Richard Dimbleby Department of Cancer Research
tope-tagging of this cDNA established its cytoplasmicICRF Laboratory
location (Zhang et al., 1998) suggesting that surfaceSt. Thomas' Hospital
RHAMM, whose cDNA structure has not yet been deter-Lambeth Palace Road
mined, was secondarily upregulated. While the HerrlichLondon SE1 7EH, United Kingdom
groups have been unable to find a v4 isoform, they and
we noted the presence of multiple RNA transcripts and
proteins, the latter even in transfected cells (HofmannReferences
et al. 1998), suggesting RHAMM is indeed subject to
Assmann, V., Marshall, Fieber, C., Hofmann, M., and Hart, I.R. (1998). extensive alternative splicing. Further, although their 95
J. Cell Sci. 111, 1685±1694. kDa protein is widely expressed, we and others (Zhang
Entwistle, J., Zhang, S., Yang, B., Wong, C., Li, Q., Hall, C.L., Jingbo, et al., 1998; references in Masellis-Smith et al., 1996,
A., Mowat, M., Greenberg, A.H. and Turley, E.A. (1995). Gene 163,
Lovvorn et al., 1998, and Nagy et al., 1998) have noted233±238.
additional, smaller, specific RHAMM protein bands in-Fieber, C., Plug, R., Sleeman, J., Dall, P., Ponta, H., and Hofmann,
cluding a 70±73 kDa isoform, whose high expression isM. (1998). Gene, in press.
transient and depends upon culture confluence (e.g.,Hall, C.L., Yang, B., Yang, X., Zhang, S., Turley, M., Samuel, S.,
references in Zhang et al., 1998). It is not obviousLange, L.A., Wang, C., Curpen, G.D., Savani, R.C, et al. (1995). Cell
82, 19±26. whether these transient RHAMM forms are detected
under the culture conditions used by the Herrlich group,Hall, C.L., Lange, L.A., Prober, D.A., Zhang, S., and Turley, E.A.
(1996). Oncogene 13, 2213±2224. making the disappearance of only 95 kDa RHAMM from
Hardwick, C., Hoare, K., Owens, R., Hohn, H.P., Hookm, M., Moore, RHAMM null mice difficult to assess. Several labs have
D., Cripps, V., Austen, L., Nance, D.M., and Turley, E.A. (1992). J. noted, by FACS, EM, and function blocking, that cell
Cell Biol. 117, 1343±1350. surface RHAMM is constitutively expressed in migratory
Hofmann, M., Fieber, C., Assmann, V., GoÈ ttlicher, M., Sleeman, J., thymocytes (see references in Masellis-Smith et al.,
Plug, R., Howells, N., von Stein, O., Ponta, H., and Herrlich, P. (1998). 1996 and Gares et al., 1998) and transiently expressed
J. Cell Sci. 111, 1673±1684.
after plating or injury of adherent cells, although the
Samuel, S.K., Hurta, R.A., Spearman, M.A., Wright, J.A., Turley, E.A.,
precise level of expression varies (e.g., Hall et al., 1995and Greenberg, A.H. (1993). J. Cell Biol. 123, 749±758.
versus Zhang et al., 1998) depending upon which of atTurley, E.A., Moore, D., and Hayden, L.J. (1987). Biochemistry 26,
least six reported antibodies are used. Although the2997±3005.
location of RHAMM in multiple cell compartments isTurley, E.A., Brassel, P., and Moore, D. (1990). Exp. Cell Res. 187,
unusual, it is not without precedence (Sheller et al.,243±249.
1998). This novel class of hyaladherins, currently incom-Wang, C., Entwistle, J., Hou, G., Li, Q., and Turley, E.A. (1996). Gene
pletely understood, promises to widen our understand-174, 299±306.
ing of how hyaluronic acid exerts its biological effects.Zhang, S., Chang, M.C.Y., Zylka, D., Turley, S., Harrison, R., and
Turley, E.A. (1998). J. Biol. Chem. 273, 11342±11348.
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